BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24632418)

  • 1. Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma.
    Mansour MA; Aljoufi MA; Al-Hosaini K; Al-Rikabi AC; Nagi MN
    Chem Biol Interact; 2014 May; 215():17-24. PubMed ID: 24632418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible antineoplastic potential of selective, irreversible proteasome inhibitor, carfilzomib on chemically induced hepatocarcinogenesis in rats.
    Mansour MA; Aljoufi MA; Al-Hosaini K; Al-Rikabi AC; Nagi MN
    J Biochem Mol Toxicol; 2014 Sep; 28(9):400-6. PubMed ID: 24861196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Nasr M; Selima E; Hamed O; Kazem A
    Eur J Pharmacol; 2014 Jan; 723():267-75. PubMed ID: 24291100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway.
    Hsu YL; Kuo PL; Cho CY; Ni WC; Tzeng TF; Ng LT; Kuo YH; Lin CC
    Food Chem Toxicol; 2007 Jul; 45(7):1249-57. PubMed ID: 17316946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1,2,4-triazole derivatives as antitumor agents against hepatocellular carcinoma.
    Radwan RR; Zaher NH; El-Gazzar MG
    Chem Biol Interact; 2017 Aug; 274():68-79. PubMed ID: 28693887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginger ingredients inhibit the development of diethylnitrosoamine induced premalignant phenotype in rat chemical hepatocarcinogenesis model.
    Mansour MA; Bekheet SA; Al-Rejaie SS; Al-Shabanah OA; Al-Howiriny TA; Al-Rikabi AC; Abdo AA
    Biofactors; 2010; 36(6):483-90. PubMed ID: 20872761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.
    Mansour MA; Al-Ismaeel H; Al-Rikabi AC; Al-Shabanah OA
    Life Sci; 2011 Aug; 89(5-6):188-94. PubMed ID: 21699905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo attenuation of angiogenesis in hepatocellular carcinoma by Nigella sativa.
    Fathy M; Nikaido T
    Turk J Med Sci; 2018 Feb; 48(1):178-186. PubMed ID: 29479981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
    Hsieh MY; Lin ZY; Chuang WL
    Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
    Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL
    J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats.
    Saleem S; Shaharyar MA; Khusroo MJ; Ahmad P; Rahman RU; Ahmad K; Alam MJ; Al-Harbi NO; Iqbal M; Imam F
    Mol Cell Biochem; 2013 Dec; 384(1-2):147-53. PubMed ID: 24026428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway.
    Darweish MM; Abbas A; Ebrahim MA; Al-Gayyar MM
    J Pharm Pharmacol; 2014 Jul; 66(7):1032-45. PubMed ID: 24611903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.
    Elewa MA; Al-Gayyar MM; Schaalan MF; Abd El Galil KH; Ebrahim MA; El-Shishtawy MM
    Clin Exp Metastasis; 2015 Jun; 32(5):479-93. PubMed ID: 25999065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.
    Uematsu S; Higashi T; Nouso K; Kariyama K; Nakamura S; Suzuki M; Nakatsukasa H; Kobayashi Y; Hanafusa T; Tsuji T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Apr; 20(4):583-8. PubMed ID: 15836707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis.
    Cong M; Liu T; Wang P; Fan X; Yang A; Bai Y; Peng Z; Wu P; Tong X; Chen J; Li H; Cong R; Tang S; Wang B; Jia J; You H
    Am J Pathol; 2013 May; 182(5):1607-16. PubMed ID: 23474083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
    Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
    Mise M; Arii S; Higashituji H; Furutani M; Niwano M; Harada T; Ishigami S; Toda Y; Nakayama H; Fukumoto M; Fujita J; Imamura M
    Hepatology; 1996 Mar; 23(3):455-64. PubMed ID: 8617424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-irradiated β-glucan modulates signaling molecular targets of hepatocellular carcinoma in rats.
    Elsonbaty SM; Zahran WE; Moawed FS
    Tumour Biol; 2017 Aug; 39(8):1010428317708703. PubMed ID: 28810822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis.
    Bishayee A; Thoppil RJ; Darvesh AS; Ohanyan V; Meszaros JG; Bhatia D
    J Nutr Biochem; 2013 Jan; 24(1):178-87. PubMed ID: 22841394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B.
    Saber S; Mahmoud AAA; Goda R; Helal NS; El-Ahwany E; Abdelghany RH
    Toxicol Lett; 2018 Oct; 295():32-40. PubMed ID: 29859236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.